WASHINGTON, DC—The American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) have released the initial findings of the 2022 National Pharmacy Workplace Survey

The American Pharmacists Association (APhA), American Society of Consultant Pharmacists (ASCP), American Society of Health System Pharmacists (ASHP), National Alliance of State Pharmacy Associations (NASPA), and the National Community Pharmacists Association (NCPA) today issued the following statement in response to the FDA’s decision to authorize the Pfizer COVID-19 oral antiviral but specifically prevent pharmacists from writing the prescriptions:

The American Association of Colleges of Pharmacy (AACP) Board of Directors and the American Pharmacists Association (APhA) Board of Trustees have approved updates to the profession’s Oath of a Pharmacist to incorporate contemporary language and address diversity, equity, inclusion, and antiracism.